Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Nuclear Medicine

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 9 articles:
HTML format

Single Articles

    May 2021
  1. JANI AB, Schreibmann E, Goyal S, Halkar R, et al
    (18)F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
    Lancet. 2021 May 7. pii: S0140-6736(21)00581.
    PubMed     Abstract available

    March 2021
  2. STEINBERG J, Thomas A, Iravani A
    (18)Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
    Lancet. 2021 Mar 8. pii: S0140-6736(21)00464.

    February 2021
  3. HOFMAN MS, Emmett L, Sandhu S, Iravani A, et al
    [(177)Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
    Lancet. 2021;397:797-804.
    PubMed     Abstract available

  4. HOPE TA, Calais J
    PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer.
    Lancet. 2021 Feb 11. pii: S0140-6736(21)00349.

    September 2020
  5. LEVY L, Meuwly JY, Sarivalasis A, Achtari C, et al
    Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
    Lancet. 2020;396:725.

    August 2020
  6. CARDENAS-DE LA GARZA JA, Esquivel-Valerio JA, Arvizu-Rivera RI, Colunga-Pedraza PR, et al
    Flushing out a plasmacytoma in a patient with POEMS and AESOP syndromes.
    Lancet. 2020;396:e21.

    July 2020
  7. CAMPBELL BCV, Khatri P
    Lancet. 2020;396:129-142.
    PubMed     Abstract available

    June 2020
  8. FORTEA J, Vilaplana E, Carmona-Iragui M, Benejam B, et al
    Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Lancet. 2020;395:1988-1997.
    PubMed     Abstract available

    April 2020
  9. GOUJARD C, Salenave S, Briot K, Chanson P, et al
    Treating hypoparathyroidism with recombinant human parathyroid hormone (1-34): long-term safety concerns.
    Lancet. 2020;395:1304.

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.